| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.4 |